Active: new fund Oct 2026 Verified 4 Nov 2026
Hatteras Venture Partners
Durham, NC healthcare venture capital firm investing in biotech, medtech and healthtech companies.
- Type
- VC firm
- Location
- Durham, North Carolina, United States
- Stages
- Seed
- Backs
- Biotech and pharma, Medtech and digital health
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- $250M Hatteras Venture Partners VII (Form D offering, 2023)
- Latest fund or filing
- 14 Oct 2026
- Portfolio mix
- Biotech and pharma 62%; Medtech and digital health 23%; B2B software 15% (n=13, 2019 to 2026)
- Website
- hatterasvp.com
Fund filings (SEC Form D)
- Latest fund on file
- Hatteras Opportunity Fund II
- Filed
- 14 Oct 2026 (new notice)
- Fund size
- $100M (total offering)
- Fund vehicles filed in the last 12 months
- 2 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Hatteras Venture Partners, the paid file holds: 8 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2159355/000215935526000001/
- adviserinfo.sec.gov/firm/summary/289173
- hatterasvp.com/
- www.sec.gov/Archives/edgar/data/1902943/000190294323000003/
- hatterasvp.com/team
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 18 lists
Venture capital firms in the Research Triangle (20)Venture capital firms in North Carolina (28)Seed biotech investors in the US (159)Seed medtech investors in the US (205)Seed medtech investors (278)Biotech venture capital firms in the US (297)Seed biotech investors (300)Medtech venture capital firms in the US (350)Seed healthtech investors in the US (437)Medtech investors (457)Biotech investors (484)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Seed investors in the US (1,043)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)